220 related articles for article (PubMed ID: 26917345)
21. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
Bernstein DI; Ireland J; Bourne N
Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368
[TBL] [Abstract][Full Text] [Related]
22. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
[TBL] [Abstract][Full Text] [Related]
23. Characterisation of penciclovir resistant acyclovir sensitive herpes simplex virus type 2 isolated from an AIDS patient.
Pardeiro M; Cuenca-Estrella M; Fernández-Clúa MA; Santos-O'Connor F; Tabarés E; Gadea I
J Med Virol; 2004 May; 73(1):60-4. PubMed ID: 15042649
[TBL] [Abstract][Full Text] [Related]
24. Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.
Burrel S; Bonnafous P; Hubacek P; Agut H; Boutolleau D
Antiviral Res; 2012 Dec; 96(3):386-90. PubMed ID: 23041200
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
Sauerbrei A; Deinhardt S; Zell R; Wutzler P
Antiviral Res; 2010 Jun; 86(3):246-52. PubMed ID: 20211650
[TBL] [Abstract][Full Text] [Related]
26. Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France.
Frobert E; Burrel S; Ducastelle-Lepretre S; Billaud G; Ader F; Casalegno JS; Nave V; Boutolleau D; Michallet M; Lina B; Morfin F
Antiviral Res; 2014 Nov; 111():36-41. PubMed ID: 25218782
[TBL] [Abstract][Full Text] [Related]
27. Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.
Watson-Jones D; Wald A; Celum C; Lingappa J; Weiss HA; Changalucha J; Baisley K; Tanton C; Hayes RJ; Marshak JO; Gladden RG; Koelle DM
J Clin Microbiol; 2010 Oct; 48(10):3496-503. PubMed ID: 20702659
[TBL] [Abstract][Full Text] [Related]
28. Differences in the Likelihood of Acyclovir Resistance-Associated Mutations in the Thymidine Kinase Genes of Herpes Simplex Virus 1 and Varicella-Zoster Virus.
Fujii H; Harada S; Yoshikawa T; Yamada S; Omura N; Shibamura M; Inagaki T; Kato H; Fukushi S; Saijo M
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858222
[TBL] [Abstract][Full Text] [Related]
29. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.
Wald A; Corey L; Cone R; Hobson A; Davis G; Zeh J
J Clin Invest; 1997 Mar; 99(5):1092-7. PubMed ID: 9062368
[TBL] [Abstract][Full Text] [Related]
30. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.
Kimberlin D; Powell D; Gruber W; Diaz P; Arvin A; Kumar M; Jacobs R; Van Dyke R; Burchett S; Soong SJ; Lakeman A; Whitley R
Pediatr Infect Dis J; 1996 Mar; 15(3):247-54. PubMed ID: 8852914
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.
Gaudreau A; Hill E; Balfour HH; Erice A; Boivin G
J Infect Dis; 1998 Aug; 178(2):297-303. PubMed ID: 9697707
[TBL] [Abstract][Full Text] [Related]
32. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
Duan R; de Vries RD; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2008 Sep; 198(5):659-63. PubMed ID: 18627246
[TBL] [Abstract][Full Text] [Related]
33. Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.
Wang K; Mahalingam G; Hoover SE; Mont EK; Holland SM; Cohen JI; Straus SE
J Virol; 2007 Jul; 81(13):6817-26. PubMed ID: 17459924
[TBL] [Abstract][Full Text] [Related]
34. Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients.
van Velzen M; Missotten T; van Loenen FB; Meesters RJ; Luider TM; Baarsma GS; Osterhaus AD; Verjans GM
J Clin Virol; 2013 Jul; 57(3):215-21. PubMed ID: 23582986
[TBL] [Abstract][Full Text] [Related]
35. Relevance of non-synonymous thymidine kinase mutations for antiviral resistance of recombinant herpes simplex virus type 2 strains.
Brunnemann AK; Hoffmann A; Deinhardt-Emmer S; Nagel CH; Rose R; Fickenscher H; Sauerbrei A; Krumbholz A
Antiviral Res; 2018 Apr; 152():53-57. PubMed ID: 29427675
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus.
Chibo D; Druce J; Sasadeusz J; Birch C
Antiviral Res; 2004 Feb; 61(2):83-91. PubMed ID: 14670581
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
38. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of acyclovir-resistant herpes simplex virus type 2 proctitis with leflunomide in an HIV-infected man.
Henao-Martínez AF; Weinberg A; Waldman WJ; Levi ME
J Clin Virol; 2012 Jul; 54(3):276-8. PubMed ID: 22465339
[TBL] [Abstract][Full Text] [Related]
40. Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.
Suzutani T; Ishioka K; De Clercq E; Ishibashi K; Kaneko H; Kira T; Hashimoto K; Ogasawara M; Ohtani K; Wakamiya N; Saijo M
Antimicrob Agents Chemother; 2003 May; 47(5):1707-13. PubMed ID: 12709344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]